Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love McKesson Corporation (NYSE:MCK)?

McKesson Corporation (NYSE:MCK) was in 43 hedge funds’ portfolio at the end of the fourth quarter of 2012. MCK investors should pay attention to an increase in hedge fund interest of late. There were 41 hedge funds in our database with MCK holdings at the end of the previous quarter.

In today’s marketplace, there are dozens of gauges shareholders can use to watch the equity markets. A pair of the most useful are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can beat the broader indices by a healthy amount (see just how much).

McKesson Corporation (NYSE:MCK)Just as beneficial, positive insider trading activity is another way to break down the marketplace. Obviously, there are plenty of incentives for an upper level exec to downsize shares of his or her company, but just one, very simple reason why they would initiate a purchase. Plenty of academic studies have demonstrated the market-beating potential of this tactic if piggybackers understand what to do (learn more here).

With all of this in mind, we’re going to take a look at the latest action encompassing McKesson Corporation (NYSE:MCK).

Hedge fund activity in McKesson Corporation (NYSE:MCK)

At the end of the fourth quarter, a total of 43 of the hedge funds we track were long in this stock, a change of 5% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were boosting their stakes considerably.

When looking at the hedgies we track, Larry Robbins’s Glenview Capital had the most valuable position in McKesson Corporation (NYSE:MCK), worth close to $228 million, accounting for 3.2% of its total 13F portfolio. The second largest stake is held by Daniel S. Och of OZ Management, with a $109 million position; 2.2% of its 13F portfolio is allocated to the company. Other hedge funds with similar optimism include Doug Silverman’s Senator Investment Group, Patrick McCormack’s Tiger Consumer Management and Jacob Gottlieb’s Visium Asset Management.

As one would reasonably expect, key hedge funds have been driving this bullishness. Senator Investment Group, managed by Doug Silverman, established the most outsized position in McKesson Corporation (NYSE:MCK). Senator Investment Group had 102 million invested in the company at the end of the quarter. Dmitry Balyasny’s Balyasny Asset Management also initiated a $10 million position during the quarter. The other funds with new positions in the stock are Barton Biggs’s Traxis Partners, Curtis Macnguyen’s Ivory Capital (Investment Mgmt), and Michael Platt and William Reeves’s BlueCrest Capital Mgmt..

How are insiders trading McKesson Corporation (NYSE:MCK)?

Bullish insider trading is best served when the company we’re looking at has seen transactions within the past six months. Over the latest six-month time period, McKesson Corporation (NYSE:MCK) has seen zero unique insiders purchasing, and 8 insider sales (see the details of insider trades here).

With the returns exhibited by Insider Monkey’s tactics, everyday investors must always keep an eye on hedge fund and insider trading sentiment, and McKesson Corporation (NYSE:MCK) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!